WSK-V104

N/A

Report date: 2026/02/10 11:21:09

Base Information

Drug NameWSK-V104
Drug Alias NameRecombinant trivalent influenza vaccine重组三价流感病毒疫苗（Sf9细胞）WSKV104WSK-V104
ClassificationVaccines > Vaccine type > Multivalent vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesChengdu WestVac Biopharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChengdu WestVac Biopharma Co Ltd
Inactive CompaniesN/A
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A